Moderna wins CDC backing for use of COVID-19 shot in teens, older children
sshepard/iStock Unreleased via Getty Images



Update: An
independent group of experts advising the
Centers for Disease Control and Prevention (CDC) unanimously voted to recommend the use of Moderna (NASDAQ:MRNA) COVID-19 vaccine for children and adolescents aged 6 â 17.

Previously: The Advisory Committee on Immunization Practices (ACIP) of the CDC are meeting on Thursday to decide whether to recommend the Moderna (MRNA) COVID-19 vaccine for children and adolescents aged 6 â 17.
After a three-hour meeting, the panel is expected to vote on its use at 1:30 EST. A rival messenger RNA vaccine from Pfizer (PFE) and BioNTech (BNTX) was available for the age group since October.
CDC advisory committees issue non-binding recommendations. However, the federal agency usually follows them for a final decision.
Just last week, the FDA amended the EUA granted for Moderna (MRNA) vaccine to add individuals aged six months to 17 years.
Later, the CDC endorsed the use of Pfizer (PFE)/ BioNTech (BNTX) and Moderna (MRNA) vaccines for children between the ages of six months and five years.